Drug Shortage Report for EMEND
| Report ID | 161154 |
| Drug Identification Number | 02298791 |
| Brand name | EMEND |
| Common or Proper name | aprepitant capsules |
| Company Name | MERCK CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | APREPITANT |
| Strength(s) | 80MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL ORAL |
| Packaging size | 2 CAP |
| ATC code | A04AD |
| ATC description | ANTIEMETICS AND ANTINAUSEANTS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | 2022-06-27 |
| Actual start date | |
| Estimated end date | 2022-06-30 |
| Actual end date | 2022-06-23 |
| Shortage status | Avoided shortage |
| Updated date | 2022-06-23 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 16750 ROUTE TRANSCANADIENNE KIRKLAND, QUEBEC CANADA H9H 4M7 |
| Company contact information | 1-800-567-2594 medinfocanada@merck.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2022-06-23 | French | Compare |
| v5 | 2022-06-23 | English | Compare |
| v4 | 2022-06-06 | French | Compare |
| v3 | 2022-06-06 | English | Compare |
| v2 | 2022-05-24 | French | Compare |
| v1 | 2022-05-24 | English | Compare |
Showing 1 to 6 of 6